Treatment Outcome and Prognosis of Patients with Lymph Node Recurrence of Thoracic Esophageal Squamous Cell Carcinoma After Curative Resection

[1] Kamangar F(2006)Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137-2150

[2] Dores GM(2000)Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study J Am Coll Surg 190 562-573

[3] Anderson WF(2000)Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225-232

[4] Daly JM(2004)Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg 198 205-211

[5] Fry WA(2003)Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 24-31

[6] Little AG(2008)Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy J Gastrointest Surg 12 802-810

[7] Ando N(2008)Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2451-2457

[8] Ozawa S(2006)Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer Oncol Rep 16 1061-1066

[9] Kitagawa Y(1995)The problems of cervico-thoraco abdominal (3-field) lymphadenectomy for thoracic esophageal cancer Ann Thorac Cardiovasc Surg 1 349-353

[10] Nakagawa S(2005)Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer Oncol Rep 13 667-672

[1] Kamangar F(2006)Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137-2150

[2] Dores GM(2000)Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study J Am Coll Surg 190 562-573

[3] Anderson WF(2000)Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225-232

[4] Daly JM(2004)Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg 198 205-211

[5] Fry WA(2003)Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 24-31

[6] Little AG(2008)Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy J Gastrointest Surg 12 802-810

[7] Ando N(2008)Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2451-2457

[8] Ozawa S(2006)Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer Oncol Rep 16 1061-1066

[9] Kitagawa Y(1995)The problems of cervico-thoraco abdominal (3-field) lymphadenectomy for thoracic esophageal cancer Ann Thorac Cardiovasc Surg 1 349-353

[10] Nakagawa S(2005)Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer Oncol Rep 13 667-672